1. Home
  2. NEXT vs ZLAB Comparison

NEXT vs ZLAB Comparison

Compare NEXT & ZLAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo NextDecade Corporation

NEXT

NextDecade Corporation

HOLD

Current Price

$5.42

Market Cap

1.6B

Sector

Energy

ML Signal

HOLD

Logo Zai Lab Limited

ZLAB

Zai Lab Limited

HOLD

Current Price

$17.51

Market Cap

2.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NEXT
ZLAB
Founded
2010
2013
Country
United States
China
Employees
N/A
N/A
Industry
Oil & Gas Production
Biotechnology: Pharmaceutical Preparations
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.6B
2.0B
IPO Year
N/A
2017

Fundamental Metrics

Financial Performance
Metric
NEXT
ZLAB
Price
$5.42
$17.51
Analyst Decision
Hold
Buy
Analyst Count
2
6
Target Price
$9.00
$57.22
AVG Volume (30 Days)
3.7M
1.0M
Earning Date
10-30-2025
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$441,629,000.00
Revenue This Year
N/A
$30.20
Revenue Next Year
N/A
$34.71
P/E Ratio
N/A
N/A
Revenue Growth
N/A
24.14
52 Week Low
$4.99
$16.82
52 Week High
$12.12
$44.34

Technical Indicators

Market Signals
Indicator
NEXT
ZLAB
Relative Strength Index (RSI) 41.70 28.36
Support Level $5.15 $16.82
Resistance Level $5.63 $18.29
Average True Range (ATR) 0.29 0.63
MACD -0.03 0.19
Stochastic Oscillator 28.97 20.29

Price Performance

Historical Comparison
NEXT
ZLAB

About NEXT NextDecade Corporation

NextDecade Corp is a Houston-based energy company engaged in construction and development activities related to the liquefaction of natural gas and sale of LNG and the capture and storage of CO2 emissions. The group is constructing and developing a natural gas liquefaction and export facility located in the Rio Grande Valley near Brownsville, Texas (the Rio Grande LNG Facility). It also engaged in NEXT Carbon Solutions advancing proprietary processes to lower the cost of utilizing carbon capture and storage (CCS) and help companies reduce their emissions and achieve their clean energy goals.

About ZLAB Zai Lab Limited

Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. The pipeline of proprietary drug candidates of the company includes ZL-1218 (CCR8) Solid Tumors, ZL-1310 (DLL3 ADC) ES-SCLC Other NECs, ZL-6301 (ROR1 ADC) Solid Tumors, ZL 6201 (LRRC15 ADC) Solid Tumors.

Share on Social Networks: